Clinical Trial Update: Levosimendan Administration in Neonates With Transposition of the Great Arteries [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating levosimendan for neonates with transposition of the great arteries, focusing on managing low cardiac output syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Cardiac Output Syndrome
• Transposition of the Great Arteries

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Low Cardiac Output Syndrome | Phase 2 | Status: COMPLETED